These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 2939788)
1. von Willebrand factor and platelet function. Moroose R; Hoyer LW Annu Rev Med; 1986; 37():157-63. PubMed ID: 2939788 [TBL] [Abstract][Full Text] [Related]
2. Interaction of the von Willebrand factor with platelets and thrombosis. Perutelli P; Mori PG Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429 [TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Favaloro EJ Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148 [TBL] [Abstract][Full Text] [Related]
5. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263 [TBL] [Abstract][Full Text] [Related]
6. The role of von Willebrand factor in platelet function. de Groot PG Semin Thromb Hemost; 2002 Apr; 28(2):133-8. PubMed ID: 11992236 [TBL] [Abstract][Full Text] [Related]
7. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355 [TBL] [Abstract][Full Text] [Related]
8. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease. Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715 [TBL] [Abstract][Full Text] [Related]
9. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358 [TBL] [Abstract][Full Text] [Related]
10. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene. Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361 [TBL] [Abstract][Full Text] [Related]
11. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469 [TBL] [Abstract][Full Text] [Related]
12. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings. Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363 [TBL] [Abstract][Full Text] [Related]
13. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060 [TBL] [Abstract][Full Text] [Related]
15. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays. Favaloro EJ Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953 [TBL] [Abstract][Full Text] [Related]
17. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies. Favaloro EJ Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology, diagnosis, and management of von Willebrand disease in India. Ghosh K; Shetty S Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205 [TBL] [Abstract][Full Text] [Related]
19. [Variant type von Willebrand disease with defective binding to factor VIII]. Shima M Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534 [No Abstract] [Full Text] [Related]
20. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]